ABSTRACT
INTRODUCTION
Inflammation and inflammatory factors play a substantial role in the formation and progression of atherosclerotic plaque, and can lead to determinatively acute thrombotic complications of atheroma.
1
Elevated leucocyte count is a marker for cardiovascular risk prediction, and the correlation between leucocyte count and the risk of cardiovascular disease has been recently demonstrated. 2, 3 However, although an increased leucocyte count is related to cardiovascular events and mortality in acute coronary syndromes (ACS), recent studies suggest that the neutrophil/ lymphocyte ratio (NLR) is a more specific determiner than the neutrophil or leucocyte count. 4 Left ventricular systolic dysfunction (LVSD) is an important cause both of mortality and morbidity in patients with ACS. In patients with ischemic or non-ischemic LVSD, the neutrophil count was demonstrated to be related with cardiovascular mortality. 5 Recent studies showed that heart failure (HF) develops more frequently in patients with STelevated ACS who have a high NLR on admission to the hospital, and that HF can occur after either a short or long period after ACS. 6 Here, we aimed to investigate the predictive value of NLR for LVSD in patients with NST-ACS.
METHODS
Enrollments of patients with ACS described as unstable angina (UA) and non-ST elevated myocardial infarction (NSTEMI) who were admitted to our institution between March 2011 and August 2013 were evaluated retrospectively. Patients with clinical evidence of cancer, chronic inflammatory disease (CID), or any systemic infection were excluded. Therefore, 405 patients who were diagnosed with NST-ACS were enrolled. The patients were divided into tertiles based on admission NLR values. The low, medium and high tertiles defined as NLR≤1.81 (n=135), 1.81<NLR≤3.2 (n=135) and NLR>3.2 (n=135), respectively.
Diagnosis of UA and NSTEMI were defined according to American College of Cardiology guideline.
7
Clinical characteristics and risk factors, i.e., smoking, hypertension (HT), and diabetes mellitus (DM) were obtained from the patients' medical records. Patients treated with antihypertensive drugs or whose baseline blood pressure was over 140/90 mmHg were diagnosed with HT. Patients with DM were identified as prediagnosed and/or being on antidiabetic medication or newly diagnosed patients whose fasting plasma glucose level was ≥126 mg/dL or blood glucose level at any time was ≥200 mg/dL. LVSD was defined as ejection fraction ≤40% measured by transthoracic echocardiography on first admission to coronary care unit.
Total leukocyte count and its subtypes and biochemical values were appreciated retrospectively from blood samples and analyzed using a Beckman Coulter LH 780 (Beckman Coulter Ireland Inc. Mervue, Galway, Ireland) device in the laboratory of our institution.
Echocardiography was performed using a machine (Vivid 7®, GE Vingmed Ultrasound A/S, Horten, Norway) with a 3.5-MHz transducer. Left ventricular ejection fraction (LVEF) was assessed by Simpson's method.
Angiographic data of the patients were evaluated from catheter laboratory records. All patients underwent a coronary angiography by the femoral approach using the standard Judkin's technique. Iopromide as a contrast agent (Ultravist-370, Bayer Schering Pharma, Germany) and 6F diagnostic catheter were used in all patients.
All statistical analyses were performed using the SPSS program (version 17.0, SPSS, Chicago, IL, 
RESULTS
A total of 405 patients (304 males and 101 females) with NST-ACS (253 NSTEMI and 152 UA) were included in the study. The patients in the high NLR group were older (p<0.001), had a higher rate of DM (p=0.028) and NSTEMI (p<0.001) and a lower LVEF (p<0.001) than did the patients in the low and medium NLR groups. Table-I summarises the baseline characteristics of the groups.
Baseline leucocyte count (p=0.02), neutrophil count (p<0.001) and NLR (p<0.001) were significantly higher and baseline haemoglobin (p=0.044), hematocrit (p=0.019) and lymphocytes (p<0.001) levels were significantly lower in the high NLR group. Table-II shows the baseline laboratory findings of the groups.
A correlation analysis found that NLR was negatively correlated with LVEF (r=−0.214, p<0.001). The relationship between LVEF and NLR in patients with NST-ACS is demonstrated in Fig.1 . Independent predictors of systolic dysfunction were determined using a backward stepwise multivariate logistic regression. Age ≥70 years, NSTEMI and NLR were found to be associated with systolic dysfunction. NLR>3.2 and age ≥70 years were found to be independent predictors of systolic dysfunction in multivariate analyses (HR:2.01, 95% CI:1.25-3.24, p=0.004; HR:1.90,95% CI:1.17-3.1, p=0.009, respectively). 
DISCUSSION
The present study shows that an NLR >3.2 was associated with LVEF ≤40 on admission of patients with NST-ACS. The study focuses on patients with LVSD and ACS, because it has long been known that ACS is associated not only with mortality but also with morbidity, and, in particular, with congestive heart failure (CHF). When HF is related to coronary artery disease (CAD), patients have higher rate of mortality. Leucocytosis is one of the common findings in acute myocardial infarction (AMI), and differential analysis of leucocytes may give additional data for the determination of high risk patients, which is an important issue in daily practice.
The total leucocyte count can be rapidly evaluated within the first hour at an emergency department; thus, it is a useful marker for diagnosis and prognosis. 8 Recent studies have demonstrated the predictive value of the leucocyte count in patients with AMI. 5, 6 Moreover, recent data have shown that certain specific leucocyte subtypes possess a greater predictive importance in the evaluation of all cardiovascular risk. Myocardial injury is followed by neutrophilia in ACS. It is also known that neutrophils can cause the release of certain substances such as proteolytic enzymes and superoxide radicals, and may thus play a role in atherosclerotic plaque rupture and aggravate the inflammatory condition. The association of neutrophils with tissue damage in MI patients has been postulated in some studies. 9 Leucocyte-platelet aggregates may lead to vascular occlusion and be liable for infarct expansion in patients with ACS. 10 Furthermore, microvascular obstruction with neutrophil-platelet plugs and vasoconstriction may cause the most extensive myocardial damage. Avanzas et al. demonstrated that a high neutrophil count is related to the extent of the infarct area in MI.
11
However, a high NLR is an indicator of a high inflammatory process and is an independent predictor for LVSD in CAD. Avci et al. have documented the neutrophi lymphocytes ratio is related to the severity of idiopathic dilated cardiomyopathy.
12
Lazaro et al. indicated that inflammatory markers are related to the functional class and prognosis in stable HF patients, and concluded that inflammation plays a key role in HF. 13 Recent studies have shown advanced HF after MI and mortality were higher in patients with a higher neutrophil count.
14 A higher NLR is associated with the severity of CAD
15
, and relative neutrophilia (together with lymphopenia) is associated with increased cardiovascular risk. 4 Lymphopenia in relation to lymphocyte apoptosis indicates the presence of a highly inflammatory process 16 , and lymphopenia occurs in acute conditions due to lymphocyte apoptosis, thereby releasing pro-inflammatory cytokines due to the apoptotic cells.
17 Dogdu et al. recently explained that a high NLR has a significant negative correlation with LVEF, and is an independent predictor of LVSD in stable multivessel CAD. 18 Similarly, in our study, high NLR (>3.2) was an independent predictor of LVSD in patients with NST-ACS. Additionally, Sulaimen et al demonstrated that admission NLR is an independent predictor of all cause mortality in ACS patients. 19 Our results suggest that a high NLR may relate to poor adaptive mechanisms in myocardial tissue, rather than to a culprit lesion or to multivessel disease. The presence of both neutrophilia and lymphopenia in patients indicate the presence of a highly inflammatory process, and inflammation is an important factor for myocardial damage in these patients.
In our study, patients with a high NLR were older and had a higher inflammatory burden due to comorbities such as DM. To the best of our knowledge, the relationship between age and NLR has not yet been investigated, and no study has yet analysed the relationship between NLR and systolic dysfunction in patients with NST-ACS. We speculate that a Adem Bekler et al. more intensive treatment method using an invasive approach may be useful to reduce HF and mortality in patients with NST-ACS and a high NLR. The present study has some limitations. First, our study was performed retrospectively and based on a relatively small group of patients. Second, one of the most important limitations was the failure to measure the LVEF of patients before their admission to hospital. Third, clopidogrel may cause neutropenia, and results may be altered in patients who have previously taken clopidogrel; however, our data were insufficient to identify clopidogrel use. Finally, we did not evaluate inflammation parameters such as high sensitivity CRP and MMP-9 that could be helpful in evaluating a high NLR.
CONCLUSION
A high NLR (>3.2) is useful predictor for LVSD in patients with NST-ACS. Total and differential leucocyte count analyses are basic and inexpensive methods for use in evaluating patients with ACS; therefore, the practice of using an NLR count on admission may be useful for identifying high-risk patients and their associated treatment methods.
